MOLBIO DIAGNOSTICS LTD (MOLBIO) financials

MOLBIO DIAGNOSTICS LTD (MOLBIO) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Molbio Diagnostics is an innovative point-of-care (POC) diagnostics company that develops affordable, rapid, and accurate diagnostic solutions for infectious and non-communicable diseases. Its flagship product, Truenat, is a portable, battery-powered PCR testing platform that delivers results withinan hour. Designed for use in resource-limited settings, it enables quick and decentralised disease…

  • Market Cap: ₹17,198Cr.
  • Current Price: ₹1,492
  • Stock P/E: 199
  • ROE: 13.8%
  • ROCE: 18.0%
  • Book Value: ₹123
  • Dividend Yield: 0.00%
  • 52W High / Low: ₹1,687/926

In Sep 2026, MOLBIO DIAGNOSTICS LTD (MOLBIO) reported sales ₹249 Cr and net profit ₹31 Cr.

Annual Mar 2026: sales ₹1,313 Cr, net profit ₹145 Cr.

Shareholding: Promoters 41.29% (Sep 2026), FIIs 1.59% (Sep 2026), DIIs 19.09% (Sep 2026), Public 38.04% (Sep 2026), No. of Shareholders 50,395% (Sep 2026).

MOLBIO quarterly results (₹ Cr.)
CategoryJun 2025Sep 2025Mar 2026Jun 2026Sep 2026
Sales95579439399249
YoY Sales growth———+319%-57%
Expenses105445332308190
Operating Profit-101341079259
OPM %-10%23%24%23%24%
Other Income12314
Interest24996
Depreciation7910814
Profit before tax-17123917642
Tax %-23%25%28%25%26%
Net Profit-1392665731
EPS in Rs-1.198.165.835.022.72
Raw PDF—————
MOLBIO profit and loss (₹ Cr.)
CategoryMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales1,2717763277569711,313
Sales growth—-39%-58%+132%+28%+35%
Expenses6764572865527461,061
Operating Profit59531940204226252
OPM %47%41%12%27%23%19%
Other Income158-21-24
Interest352568923
Depreciation124219242636
Profit before tax54925823152188198
Tax %25%27%32%27%26%27%
Net Profit41018716111140145
EPS in Rs40.5816.641.389.8812.4012.83
Dividend Payout %0%0%0%0%0%0%
MOLBIO balance sheet (₹ Cr.)
CategoryMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital222221112
Reserves3336817378489881,1231,405
Borrowings257105577026346251
Other Liabilities21585123157291260293
Total Liabilities8068749201,0771,3071,7411,961
Fixed Assets55182189209215257247
CWIP10000218616
Investments99545495317318
Other Assets6436836768139801,1601,381
Total Assets8068749201,0771,3071,7411,961
MOLBIO cash flows (₹ Cr.)
CategoryMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity344986838249-38
Cash from Investing Activity-142-87-51-31-98-256
Cash from Financing Activity-192-2031-24-17292
Net Cash Flow10-948-18133-2
Free Cash Flow212355524206-74
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit78%53%251%39%139%6%
MOLBIO shareholding pattern (%)
CategorySep 2026
Promoters41.29%
FIIs1.59%
DIIs19.09%
Public38.04%
No. of Shareholders50,395
MOLBIO key ratios
CategoryMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days6111319417486100
Inventory Days261402885393395286
Days Payable12464201129226130
Cash Conversion Cycle198450877438254256
Working Capital Days75206479239155143
ROCE %—41%4%22%21%18%
MOLBIOUpdated 13 Nov 2026, 12:46

Molbio Diagnostics Ltd

Market Cap

₹17,198Cr.

Current Price

₹1,492

High / Low

₹1,687/926

Stock P/E

199

ROE13.8%
ROCE18.0%
Book Value₹123
Face Value₹1.00
Dividend Yield0.00%

About

Molbio Diagnostics is an innovative point-of-care (POC) diagnostics company that develops affordable, rapid, and accurate diagnostic solutions for infectious and non-communicable diseases. Its flagship product, Truenat, is a portable, battery-powered PCR testing platform that delivers results withinan hour. Designed for use in resource-limited settings, it enables quick and decentralised disease diagnosis at the point of care.Through its wholly owned subsidiary,Bigtec Labs, Molbio has strong researchand development capabilities focused on creating diagnostic platforms for point-of-care (POC) testing. From product development to large-scale deployment, the company aimsto improve access to reliable and affordable healthcare for everyone.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Sep 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days6111319417486100
Inventory Days261402885393395286
Days Payable12464201129226130
Cash Conversion Cycle198450877438254256
Working Capital Days75206479239155143
ROCE %—41%4%22%21%18%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of MOLBIO DIAGNOSTICS LTD (MOLBIO)?

The reported market capitalisation for MOLBIO DIAGNOSTICS LTD (MOLBIO) is ₹17,198Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of MOLBIO?

The current price shown for MOLBIO DIAGNOSTICS LTD (MOLBIO) on Fincrux is ₹1,492 with a 52-week high/low of ₹1,687/926.

What is the P/E ratio of MOLBIO DIAGNOSTICS LTD (MOLBIO)?

The stock P/E for MOLBIO DIAGNOSTICS LTD (MOLBIO) is 199 on Fincrux, with ROE at 13.8% and ROCE at 18.0%.

What were MOLBIO latest quarterly results?

For Sep 2026, MOLBIO DIAGNOSTICS LTD (MOLBIO) reported sales ₹249 Cr and net profit ₹31 Cr (figures in ₹ crore unless noted).

What are MOLBIO annual sales and net profit?

For Mar 2026, MOLBIO DIAGNOSTICS LTD (MOLBIO) shows sales of ₹1,313 Cr and net profit of ₹145 Cr on the Fincrux profit & loss statement.

Who owns MOLBIO DIAGNOSTICS LTD (MOLBIO)?

Latest shareholding for MOLBIO DIAGNOSTICS LTD (MOLBIO) on Fincrux: Promoters 41.29% (Sep 2026), FIIs 1.59% (Sep 2026), DIIs 19.09% (Sep 2026), Public 38.04% (Sep 2026), No. of Shareholders 50,395% (Sep 2026).

Where can I find MOLBIO DIAGNOSTICS LTD (MOLBIO) financials?

MOLBIO DIAGNOSTICS LTD (MOLBIO) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show MOLBIO balance sheet and cash flow?

Yes. The MOLBIO DIAGNOSTICS LTD (MOLBIO) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.